Invitro

What Invitro does

INVITRO (ИНВИТРО) is a Russian private clinical diagnostic laboratory network founded in 1998 and headquartered in Moscow. The company operates 1,850+ medical offices (медофисы) across Russia and is staffed by 1,350+ physicians, delivering an integrated healthcare services platform that combines laboratory testing, physician consultations, diagnostic imaging (ultrasound, ECG), home visits, and packaged health checkup programs. Its core technical asset is a centralized high-throughput laboratory operation processing more than 260,000 tests per day across a catalog of over 3,000 test types, ranging from basic blood chemistry and hematology to advanced genetic diagnostics, НИПТ prenatal testing, and ImmunoCAP allergy panels.

The business operates a hybrid B2C/B2B model. Direct-to-consumer services are sold to individual patients on a pay-as-you-go basis at per-test prices ranging from approximately 370 RUB (basic glucose) to 7,390 RUB (extended biochemistry), with promotional discounts of up to 45% and a cashback loyalty program. A dedicated enterprise sales motion serves medical organizations (lab outsourcing, certification, referral partnerships), non-medical corporations (employee wellness and occupational health contracts), and franchise partners who operate INVITRO-branded offices under licensing agreements. Distribution is multi-channel: the 1,850+ owned and franchised offices provide physical reach, supplemented by a patient-facing mobile app, a website (invitro.ru), Viber chat support, and home-visit collection services. The company is privately held as a Russian LLC (ООО «ИНВИТРО-Объединенные коммуникации») with no disclosed parent company, funding rounds, or acquisitions.

Name

Invitro

Legal name

Общество с ограниченной ответственностью «ИНВИТРО-Объединенные коммуникации» (Limited Liability Company INVITRO-United Communications)

Website

https://invitro.ru

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

INVITRO (ИНВИТРО) is a Russian private clinical diagnostic laboratory network founded in 1998, operating 1,850+ medical offices nationwide and processing 260,000+ tests daily across a 3,000-test menu, serving individual patients, medical organizations, and corporate clients via B2C, B2B, and franchise models.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

akta.pro secondary industry

Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN)

Keywords

• Clinical laboratory diagnostics
• Medical testing services
• Diagnostic health checkups
• Physician consultation services
• Home sample collection

Headquarters

HQ city

Moscow

HQ country

Russia

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Individual Patient Testing: Direct payment by individual patients for laboratory tests and diagnostic services at medical offices or through home visits
2. Corporate/Enterprise Testing Contracts: B2B contracts with medical organizations, corporations, and institutions for employee health screening and diagnostic services
3. Franchise Revenue: Franchise model allowing partners to operate INVITRO-branded medical offices under licensing agreement
4. Doctor Consultation Services: Revenue from physician consultations, specialist appointments, and integrated medical services including consultation, research, and treatment prescription in single visit

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

INVITRO operates Russia's largest private network of clinical diagnostic laboratories, providing more than 3,000 types of medical laboratory analyses, physician consultations, diagnostic imaging procedures, and home-visit sample collection. The company runs 1,850+ medical offices and processes over 260,000 tests daily, serving individual patients as well as medical organizations and corporate clients through direct offices, franchise partners, and a mobile application.

Product overview

INVITRO is a medical diagnostic company operating clinical and diagnostic laboratories across Russia. The company provides a unified healthcare services platform combining physical medical offices (over 1,850 locations) with digital services. The core product portfolio includes medical laboratory analyses (over 3,000 types), physician appointments, diagnostic imaging services, home visit services, and comprehensive health checkup programs. A mobile application complements the service offering for patients to access results and monitor health. The company processes over 260,000 tests daily through a network of more than 1,350 physicians.

Differentiator

Problem solved

Functional benefit

Brands

• ИНВИТРО: Medical diagnostic laboratory network providing clinical tests, doctor consultations, and diagnostic services

Products and services

• INVITRO Medical Analyses (Laboratory Testing) Clinical and diagnostic laboratory testing service offering over 3,000 types of medical analyses, ranging from general blood tests to advanced genetic and molecular diagnostics, available to individual patients, medical organizations, and corporate clients.
• Doctor Appointments (Physician Consultations) Physician consultation services across multiple specialties including pediatrics, therapy, gynecology, and other specialties, integrated with on-site laboratory diagnostics.
• Diagnostic Services (Instrumental Examinations) Instrumental diagnostic examinations including ultrasound (УЗИ), ECG, and other diagnostic procedures performed at INVITRO medical offices.
• Home Visit Services (Выезд на дом) Medical services delivered at the patient's home, including blood sample collection, examinations, and other home-based diagnostic services for individual patients.
• Checkups (Чекапы) Comprehensive health examination programs combining multiple laboratory analyses, diagnostic studies, and physician consultations with individual medical conclusions.
• INVITRO Mobile Application Patient-facing mobile application providing access to laboratory test results, notifications upon analysis completion, appointment scheduling, and dynamic health monitoring for INVITRO customers.

Quantifiable outcome

• 260,000+ tests per day processing capacity
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core.

• Partner Clinics (Клиники-партнеры)coreChannel Partner/ Reseller/ DistributorNetwork of partner medical clinics referring patients to INVITRO for laboratory diagnostic services. Provides laboratory testing services to patients referred through partner network.
• Medical Organizations (Медицинским организациям)coreStrategic or Co-development PartnerPartnership with medical facilities for laboratory outsourcing, diagnostic services, and integrated healthcare delivery. Services include laboratory testing, certification, and testing laboratory services.
• Non-Medical Organizations (Немедицинским организациям)coreChannel Partner/ Reseller/ DistributorCorporate wellness partnerships with non-medical organizations providing employee health screening and occupational health services.
• Franchise PartnerscoreChannel Partner/ Reseller/ DistributorIndependent operators licensed to establish and operate INVITRO-branded medical offices under franchise agreement. Provides brand, technology, operational support, and testing services.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Gemotest (Гемотест): One of the largest Russian private clinical laboratory networks, operating hundreds of patient service centers across Russia. Directly comparable on consumer lab testing, broad test menu, B2B corporate services, and franchise-like expansion model.
• Helix (Хеликс): Major Russian private lab chain with a national network of medical offices and a strong genetic and specialty testing offering. Closely comparable on test menu breadth, DTC positioning, and digital results platform.
• KDL (KDL Lab): Russian clinical diagnostic laboratory network with broad patient office coverage and a focus on routine and specialized testing. Comparable in scale, multi-channel DTC/B2B mix, and franchise-like office expansion.
• CITILAB (СИТИЛАБ): Federal Russian network of clinical diagnostic laboratories with widespread patient offices. Directly comparable across consumer lab testing, broad assay menu, and partner-clinic referral relationships.
• LabQuest (ЛабКвест): Russian private lab operator with multiple patient service offices and a focus on routine and molecular diagnostics. Comparable on consumer-facing lab services, multi-office footprint, and B2B partnerships.
• CMD (Center for Molecular Diagnostics): Russian clinical laboratory network providing routine and specialized molecular diagnostics through patient offices. Comparable on test menu breadth and DTC lab service delivery model.

Broad incumbents

• Quest Diagnostics: One of the largest clinical laboratory companies globally, offering routine and esoteric testing, employer health services, and a national patient service center network. Provides a broader-incumbent reference point on lab network economics, even though it does not directly compete in Russia.
• Laboratory Corporation of America (Labcorp): Large US-listed clinical laboratory business with broad routine and specialty diagnostics, including consumer-initiated testing. Useful broader-incumbent benchmark for the clinical lab network model INVITRO operates, though geographically separate.
• SYNLAB: Europe's largest clinical diagnostics and medical services provider, operating patient service centers and central labs across multiple countries. Relevant broader-incumbent comparator on European-scale lab network operations and B2B medical services.
• Sonic Healthcare: International clinical pathology and radiology services group with central labs and patient collection networks across multiple geographies. Comparable as a broad-incumbent lab services operator, though not directly active in Russia.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/invitro

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Invitro